封面
市場調查報告書
商品編碼
1982470

全球核酸萃取設備市場規模、佔有率、趨勢和成長分析報告(2026-2034年)

Global Nucleic Acid Extraction Instrument Market Size, Share, Trends & Growth Analysis Report 2026-2034

出版日期: | 出版商: Value Market Research | 英文 147 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

核酸萃取設備市場預計將從 2025 年的 598 萬美元成長到 2034 年的 1,598 萬美元,2026 年至 2034 年的複合年成長率為 11.54%。

由於分子診斷和基因研究需求的不斷成長,全球核酸萃取設備市場正經歷顯著成長。核酸萃取設備用於從生物樣本中分離DNA和RNA,從而為醫學診斷、生物技術研究和藥物開發等後續分析奠定基礎。這些設備在現代臨床檢測和基因研究中發揮著至關重要的作用。

推動該市場成長的關鍵因素有很多。分子診斷檢測和基因研究計畫的擴展增加了對可靠萃取技術的需求。自動化設備有助於實驗室快速且準確地處理大量檢體。此外,生物技術和基因組學的進步也擴大了核酸分析的應用範圍。

隨著基因研究和個人化醫療的進步,核酸萃取設備市場預計將持續成長。自動化程度的提高和高通量系統的應用將提升檢查室效率。對生物技術研究和診斷基礎設施投資的增加將進一步推動全球市場擴張。

目錄

第1章:引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章 全球核酸萃取設備市場:按類型分類

  • 市場分析、洞察與預測
  • 裝置
  • 試劑和試劑盒

第5章 全球核酸萃取設備市場:依應用領域分類

  • 市場分析、洞察與預測
  • 臨床診斷
  • 研究
  • 法醫學
  • 其他

第6章 全球核酸萃取設備市場:依最終用戶分類

  • 市場分析、洞察與預測
  • 醫院/診斷檢查室
  • 學術研究機構
  • 製藥和生物技術公司

第7章 全球核酸萃取設備市場:依地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第8章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴(根據現有資訊)
  • 市場佔有率和市場定位分析(基於現有資訊)
  • 供應商情況(基於現有資訊)
  • 策略規劃

第9章:公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Thermo Fisher Scientific Inc
    • QIAGEN NV
    • Merck KGaA
    • Hoffmann-La Roche AG
    • Agilent Technologies Inc
    • Bio-Rad Laboratories Inc
    • Illumina Inc
    • PerkinElmer
    • Promega Corporation
    • New England Biolabs
    • Takara Bio Inc
    • Eppendorf AG
    • Beckman Coulter
    • LGC Biosearch Technologies
    • Omega Bio-Tek Inc
簡介目錄
Product Code: VMR11211973

The Nucleic Acid Extraction Instrument Market size is expected to reach USD 15.98 Million in 2034 from USD 5.98 Million (2025) growing at a CAGR of 11.54% during 2026-2034.

The global nucleic acid extraction instrument market has grown significantly due to increasing demand for molecular diagnostics and genetic research. Nucleic acid extraction instruments are used to isolate DNA and RNA from biological samples, enabling further analysis in medical diagnostics, biotechnology research, and pharmaceutical development. These instruments play a crucial role in modern laboratory testing and genetic studies.

Several key factors are driving the growth of this market. The expansion of molecular diagnostic testing and genetic research programs has increased demand for reliable extraction technologies. Automated instruments help laboratories process large numbers of samples quickly and accurately. Additionally, advancements in biotechnology and genomics are expanding the applications of nucleic acid analysis.

In the future, the nucleic acid extraction instrument market is expected to continue growing as genetic research and personalized medicine advance. Improved automation and high-throughput systems will enhance laboratory efficiency. Increasing investments in biotechnology research and diagnostic infrastructure will further support market expansion worldwide.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type

  • Instruments
  • Reagents & Kits

By Application

  • Clinical Diagnostics
  • Research
  • Forensic
  • Others

By End User

  • Hospitals & Diagnostic Laboratories
  • Academic & Research Institutes
  • Pharmaceutical & Biotechnology Companies

COMPANIES PROFILED

  • Thermo Fisher Scientific Inc, QIAGEN NV, Merck KGaA, HoffmannLa Roche AG, Agilent Technologies Inc, BioRad Laboratories Inc, Illumina Inc, PerkinElmer, Promega Corporation, New England Biolabs, Takara Bio Inc, Eppendorf AG, Beckman Coulter, LGC Biosearch Technologies, Omega BioTek Inc
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL NUCLEIC ACID EXTRACTION INSTRUMENT MARKET: BY TYPE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Type
  • 4.2. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Reagents & Kits Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL NUCLEIC ACID EXTRACTION INSTRUMENT MARKET: BY APPLICATION 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Application
  • 5.2. Clinical Diagnostics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Research Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Forensic Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL NUCLEIC ACID EXTRACTION INSTRUMENT MARKET: BY END USER 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast End User
  • 6.2. Hospitals & Diagnostic Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Academic & Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Pharmaceutical & Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL NUCLEIC ACID EXTRACTION INSTRUMENT MARKET: BY REGION 2022-2034(USD MN)

  • 7.1. Regional Outlook
  • 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.2.1 By Type
    • 7.2.2 By Application
    • 7.2.3 By End User
    • 7.2.4 United States
    • 7.2.5 Canada
    • 7.2.6 Mexico
  • 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.3.1 By Type
    • 7.3.2 By Application
    • 7.3.3 By End User
    • 7.3.4 United Kingdom
    • 7.3.5 France
    • 7.3.6 Germany
    • 7.3.7 Italy
    • 7.3.8 Russia
    • 7.3.9 Rest Of Europe
  • 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.4.1 By Type
    • 7.4.2 By Application
    • 7.4.3 By End User
    • 7.4.4 India
    • 7.4.5 Japan
    • 7.4.6 South Korea
    • 7.4.7 Australia
    • 7.4.8 South East Asia
    • 7.4.9 Rest Of Asia Pacific
  • 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.5.1 By Type
    • 7.5.2 By Application
    • 7.5.3 By End User
    • 7.5.4 Brazil
    • 7.5.5 Argentina
    • 7.5.6 Peru
    • 7.5.7 Chile
    • 7.5.8 South East Asia
    • 7.5.9 Rest of Latin America
  • 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.6.1 By Type
    • 7.6.2 By Application
    • 7.6.3 By End User
    • 7.6.4 Saudi Arabia
    • 7.6.5 UAE
    • 7.6.6 Israel
    • 7.6.7 South Africa
    • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

  • 8.1. Recent Developments
  • 8.2. Company Categorization
  • 8.3. Supply Chain & Channel Partners (based on availability)
  • 8.4. Market Share & Positioning Analysis (based on availability)
  • 8.5. Vendor Landscape (based on availability)
  • 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL NUCLEIC ACID EXTRACTION INSTRUMENT INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Company Profiles
    • 9.2.1 Thermo Fisher Scientific Inc
    • 9.2.2 QIAGEN N.V
    • 9.2.3 Merck KGaA
    • 9.2.4 Hoffmann-La Roche AG
    • 9.2.5 Agilent Technologies Inc
    • 9.2.6 Bio-Rad Laboratories Inc
    • 9.2.7 Illumina Inc
    • 9.2.8 PerkinElmer
    • 9.2.9 Promega Corporation
    • 9.2.10 New England Biolabs
    • 9.2.11 Takara Bio Inc
    • 9.2.12 Eppendorf AG
    • 9.2.13 Beckman Coulter
    • 9.2.14 LGC Biosearch Technologies
    • 9.2.15 Omega Bio-Tek Inc